Silent Time-Bomb, Mesothelioma
|
|
|
- Winifred Tucker
- 10 years ago
- Views:
Transcription
1 Silent Time-Bomb, Mesothelioma ーClinical Pathology Shotaro Maeda Tama-Nagayama Hospita,lNippon Medical School JAPAN
2 Mesothelioma 1 General remarks 2 Pathology 3 Cytology 4 6 cases of the mesothelioma diagnosed by cytological materials The utility of cell transfer method and cell block method for immunochemical staining
3 Mesothelioma 1 General remarks 2 Pathology 3 Cytology 4 6 cases of the mesothelioma diagnosed by cytological materials The utility of cell transfer method and cell block method for immunochemical staining
4 A quiet time bomb Mesothelioma More than 80 to 90% cases of mesothelioma occur because of exposure to asbestos(amocyte and crocidolite are considerably more potent than chrysotile,, and crocidolite is more dangerous than amosite.) In Japan a large quantity of asbestos was imported in 1970 to 1990 as well as in Thailand. It is considered that patient shows symptom of mesothelioma after about 40 years being exposed to asbestos. So, mesothelioma will be considered to occur in high frequency in 2010 to I worry that the same situation will occur in Thailand as well.
5 The volume of asbestos import in Japan ERCA The number of death due to mesothelioma The number of accidents authorizaed by government
6 Mesothelioma Lung cancer The number of asbestos related mesothelioma and lung cancer authorized by government 独 立 法 人 環 境 再 生 保 全 機 構
7 Mesothelioma The first case of mesothelioma Klemperer,P.&Robin,C.B Robin,C.B.:.: Primary neoplasms of the pleura. A report of five cases. Arch.Pathol.11: , 412, The first case report of mesothelioma by asbestos exposure Wagner JC, Sleggs CA, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North-Western Cape province. Br J Indust Med 17: , 271, 1960 A A report of 28 cases of mesothelioma by asbestos exposure in an asbestos mine of South Africa --- At that time Wagner was critisized--- At that time Wagner was bitterly
8 Mesothelioma A malignant tumor to occur to a body cavity (pleura, peritoneum, peicardium) and tunica vaginalis testis. Pleura Peritoneum Pericardium Tunica vaginalis testis 80~90% 10~20% about 1~ 5% 0.1~ 2% about 80 about 10 about about 0.1 Frequency: man78%>woman >woman22% (Occupation characteristics) Average age: about 60 years old
9 Benign Adenomatoid tumor Mesothelioma (Japan Lung Cancer Society 2003; 003; WHO 1999) Malignant mesothelioma Epi thelioid mesothelioma 50~60 60% Sarcmatoid mesothelioma 10~20 ~20% Desmoplastic mesothelioma very difficult Biphasic mesothelioma 20~30% ~30% Others
10 Benign Mesothelioma (Japan Lung Cancer Society 2003; 003; WHO 2004) Adenomatoid tumor Malignant mesothelioma Epi thelioid mesothelioma Sarcmatoid mesothelioma Desmoplastic mesothelioma Biphasic mesothelioma Others
11 In mesothelioma, body fluid accumulates in early stages because it is derived from the serous membrane different from other malignant tumors. Therfore,, body fluid cytology is very important for early detection and early treatment of mesothelioma. The prognosis of mesothelioma in early stages(stage Ia to Ib) has become better recently because of pleuropulmonary resection Stage 1a: parietal pleura Stage 1b: parietal pleura and visceral pleura Therefore, misdiagnosis for mesothelioma by body fluid cytology in early stages means that the chance of survivals of a patient is lost.
12 Clinical Clinical findings Diagnosis & Therapy (Japan) Asbestos exposure career, a symptom, an image, hyaluronic acid values of effusion 100,000ng/ml ;highly suspicious of mesothelioma Asbestos exposure career: about 40% ( occupation career) Living environment of asbestos exposure should be examined more. Asbestos exposure career: about 40% ( Diagnosis rate by cytology and histology Cytology (body fluid): about 30 to 40% Core Needle biopsy: about 20~80 80% Thoracoscopic pleural biopsy: 98% Cytologists(MD.CT) should make an effort to improve the diagnosis rate by cytology. TherapyTherapy Chemotherapy: Radiotherapy: Operation: 3 years survival rate of pleuroneumonectomy: : about 50% An An early diagnosis and an early treatment of mesothelioma are very important. So, we should study cytology of mesothelioma more seriously!!!
13
14 1 General remarks 2 Pathology 3 Cytology Mesothelioma 4 Six cases of the mesothelioma diagnosed only by cytological materials The utility of cell transfer method and cell block method for immunocytochemical staining
15 Benign Mesothelioma (Japan Lung Cancer Society 2003; 003; WHO 2004) Adenomatoid tumor Malignant mesothelioma Epi thelioid mesothelioma Sarcmatoid mesothelioma Desmoplastic mesothelioma Biphasic mesothelioma Others
16 Calretinin Epithelioid mesothelioma (tubulopapillary)
17 Calretinin Epithelioid mesothelioma (papillary)
18 Epithelioid mesothelioma Calretinin (tubular) mesothelioma (tubular)
19 Calretinin Epithelioid mesothelioma(solid)
20 Calretinin Sarcomatoid mesothelioma
21 Desmoplastic mesothelioma(who2004 WHO2004) Calretinin
22 Biphasic mesothelioma CK7 Calretinin
23
24 1 General remarks 2 Pathology 3 Cytology Mesothelioma 4 Six cases of the mesothelioma diagnosed only by cytological materials The utility of cell transfer method and cell block method for immunocytochemical staining
25 Differential Diagnosis Mesothelioma(Epithelial) VS Adenocarcinoma Reactive mesothelial cell
26 We love cytology
27 STUDY DESIGN About 2 years ago, we studied 10 cases of mesothelioma that were diagnosed by body fluid cytology in Nippon Medical School. Pleura: 6 cases Peritoneum: 2 cases Pericardium: 1 case Tunica vaginalis testis: 1 case
28 Thickened pleura Binucleated mesothelioma cells
29 70 -year-old womnan Pericadial mesothelioma
30 40-year-old male Mesothelioma of the tunica vaginalis testis
31 Characteristic cytological findings of mesothelioma numerous mesothelioma cells Variety of the cells; Single or groups consisting of many cells
32 Numerous, large to small clusters Scattered cells
33 Mesothelioma Variety of the cells; Large to small clusters (Papillary ~spherical) or s or single of numerous cells Reactive mesothelial cells Uniformity of the cells
34 Binucleated cells Prominent nucleoli
35 multinucleated cells with prominent nucleoli
36 Pair cells(cell mutual inclusions)
37 pair cells (cell mutual inclusions) with hump-like protruded cytoplasm
38 Differential Diagnosis Mesothelioma(Epithelial) VS Reactive mesothelial cells Adenocarcinoma
39 Mesothelioma (epithelial) Reactive mesothelial cells Adenocarcinoma nucleus nucleoli cytoplasm round to oval centrally located prominent dense cell border: unclear round to oval centrally located not prominent dense cell border: unclear irregular eccentrically centrically located clear~den dense cell border :clear PAS Alcian blue +(intracytoplasm intracytoplasm) digested in diastase +(cell surface intracytoplasm intracytoplasm) digested by hyaluronidase ±(inracytoplasm) digested by diastase +~±(intracytoplasm intracytoplasm:droplet~diffuse)not not digested in diastase +(intracytoplasm intracytoplasm) Not digested by hyaluronidase Useful antibody Calretinin Thrombomodulin HBME1 Mesothelin CK 5/6 AE1/AE3(pan-cytokeratin) WT-1 D2-40 ~ ± + ± CK7.CK20 CEA Ber-EP4 MOC31 31 CAM5.2 34βE12 & 35βH11H11 Electron microscope Numerous, long microvilli Tonofilament Glycogen A few, scattered short microbill Tonofilament Glycogen A few, short microvilli Tonofilament Glycogen
40 mesothelioma Reactive mesothelialcells Adenocarcinoma
41 Mesothelioma (epithelial) Reactive mesothelial cells Adenocarcinoma nucleus cytoplasm PAS Round to oval Centrally located Cell border: unclear + (intracytoplasm) digested by diastase a a few small clucters Binucleated~multnuleated cells pair cells (cell mutual inclusion) with hump-like protruded cytoplasm Prominent nucleoli ± (intracytoplasm) digested by diastase irregular Excentrically located Cell border: clear +~± (intracytoplasm) droplet~diffuse diffuse) not digested by diastase Alcian blue + (cell surface intracytoplasm) digested by hyaluronidase + (cell surface) digested by hyaluronidase + (intracytoplasm) not digested by hyaluronidase Useful antibody Calretinin Thrombomodulin HBME1 Mesothelin CK 5/6 AE1/AE3(pan (pan-cytokeratin) WT-1 D2-40 ~ ± + ± CK7.CK20 CEA Ber-EP4 MOC31 CAM5.2 34βE12 & 35βH11 Electron microscope Numerous, long microvilli Tonofilament Glycogen A few, scattered short microbill Tonofilament Glycogen A few, short microvilli Tonofilament Glycogen
42 Mesothelioma Reactive mesothelial cell Adenocarcinoma PAS
43 Mesothelioma (epithelial) Reactive mesothelial cells Adenocarcinoma nucleus cytoplasm Round to oval Centrally located Cell border: unclear a a few small clucters Binucleated~multnuleated cells pair cells (cell mutual inclusion) with hump-like protruded cytoplasm Prominent nucleoli irregular Excentrically located Cell border: clear PAS + (intracytoplasm) digested by diastased ± (inracytoplasm) digested by diastase +~ +~±(intracytoplasm) droplet ~diffuse) not digested by diastase Alcian blue + (cell surface intracytoplasm) digested by hyaluronidase + (cell surface) digested by hyaluronidase + (intracytoplasm) not digested by hyaluronidase Useful antibody Calretinin Thrombomodulin HBME1 Mesothelin CK 5/6 AE1/AE3(pan (pan-cytokeratin) WT-1 D2-40 ~ ± + ± CK7.CK20 CEA Ber-EP4 MOC31 CAM5.2 34βE12 & 35βH11 Electron microscope Numerous, long microvilli Tonofilament Glycogen A few, scattered short microbill Tonofilament Glycogen A few, short microvilli Tonofilament Glycogen
44 Alcian blue Mesothelioma Mesothelial cell Adenocarcinoma
45 Mesothelioma (epithelial) Reactive mesothelial cells Adenocarcinoma nucleus cytoplasm Round to oval Centrally located Cell border: unclear a a few small clucters Binucleated~multnuleated pair cells (cell mutual inclusion) with hump-like protruded cytoplasm Prominent nucleoli uniformity cells irregular Excentrically located Cell border: clear PAS Alcian blue Useful antibody +(intracytoplasm intracytoplasm) digested in diastase +(cell surface intracytoplasm intracytoplasm) digested by hyaluronidase Calretinin (+) CK 5/6 (+) D2-40 (+) (+) Thrombomodulin (+) Mesothelin(+) EMA (+) E-cadherin(+) P53(+) ±(inracytoplasm) digested in diastase Calretinin (+) CK 5/6 (+) D2-40 (+) (+) Thrombomodulin (+) Mesothelin (+) +) EMA(ー ~±) E-cadherin(ー ~±) P53(ー ~±) +~±(intracytoplasm intracytoplasm:droplet~diffuse) not digested in diastase +(intracytoplasm intracytoplasm) Not digested by hyaluronidase CEA(+) MOC31 31(+) Ber-EP4 EP4(+) Electron microscope Numerous, long microvilli Tonofilament Glycogen A few, scattered short microbill Tonofilament Glycogen A few, short microvilli Tonofilament Glycogen
46 The results of immunocytochemical staining for reactive mesothelial cells(13 cases) frequency of positive cases p53 2/13 ( 15 % ): only for a few cells EMA 3/13 ( 23 % ): weakly positive E-cadherin 0/13 ( 0 % )
47 How we can perform the immunochemical staining for several antibodies using body fluid.
48 Cell block method 1. Body fluid 2. Centrifuge at 1500rpm for 5minutes 3.Fixtation 4. Cell block 5.Immunochemical staining
49 Cell transfer method 1. Taking off the cover glass 2.Pasting the mount 3.Softening the mount 4.Taking off the mount &Trimming 5.Transfer
50 Cell block method 1. Body fluid 2. Centrifuge at 1500rpm for 5minutes 3.Fixtation 4. Cell block 5.Immunochemical staining 1.Ask clinical department to submit as much body cavity fluid as possible. 2.Centrifuge the body cavity fluid (1500 rpm for 5 minutes). 3.Decant the supernatant into another container, add 1-2 ml of 20% formalin to the supernatant, and fix overnight. 4.Embed the pellets in paraffin to prepare cell blocks. 5.Carry out immunochemical staining.
51 Cell transfer method 1. Taking off the cover glass 2.Pasting the mount 3.Softening the mount 4.Taking off the mount &Trimming 5.Transfer 1. Removal of the cover glass: Remove the cover glass with xylene. 2. Pasting the mount: Dilute malinol with xylene two times and apply it to the cell smear surface. Fix the mounted specimen by placing the glass slide on a hot plate at 75 C. Fix the specimen for 30 minutes to allow the malinol membrane to harden. 3. Softening the mount: Place the glass slide in a water bath at approximately 50 C for about 15 minutes to soften the mounting medium. 4. Removal of the mount and trimming: Take out the glass slide from the water bath and trim the softened malinol membrane using a pair of tweezers and a razor. 5. Cell transfer: Mount the trimmed softened malinol membrane to other glass slides. Dry the glass slides on a 75 C hot plate for about 30 minutes. After removing the malinol with xylene, carry out immunocytochemical staining.
52 アユタヤ
53 CEA Immunohistochemical staining using cell tranfer method in a case of mesothelioma Calretinin mesothelin l
54 An estimate of histology and primary site by a combination of CK 7 & CK20 CK7 + CK20 + CK20 - Transitional cell carcinoma Mucinous adenocarcinoma(ovary) Adenocarcinoma ( pancreas) Mesothelioma Adenocarcinoma(Lung,breast) Serous adenocarcinoma(ovary) Endometrioid adenocarcinoma(uterus) CK7 - Adenocarcinoma(stomach,, colon) Squamous cell carcinoma Renal cell carcinoma Hepatocellular carcinoma Adenocarcinoma(prostate)
55 CEA CK20 Immunohistochemical staining using cell tranfer method in a case of mesothelioma Calretinin mesothelin l CK7
56 EMA E-Cadherin p53 A case of mesothelioma Immunocytochemical staining using cell transfer technique
57 EM sample procedure on Cell block Smear sample It takes 2 to 3 days --- cytocentrifuge glutaraldehyde fixation wash osmium tetroxyde post- fixation dyhydration epoxy resin electronmicroscope semi section staind with uranyl acetate and lead citrate ultrathin section Embedded in quetol 812 ( 60 )
58 Mesothelioma (epithelial) Reactive mesothelial cells Adenocarcinoma nucleus cytoplasm Round to oval Centrally located Cell border: unclear a a few small clucters Binucleated~multnuleated pair cells (cell mutual inclusion) with hump-like protruded cytoplasm Prominent nucleoli uniformity cells irregular Cell border:nclear PAS Alcian blue +(intracytoplasm intracytoplasm) digested in diastase +(cell surface intracytoplasm) digested by hyaluronidase ±(inracytoplasm) digested in diastase +~±(intracytoplasm intracytoplasm:droplet~diffuse)not digested in diastase +(intracytoplasm intracytoplasm) Not digested by hyaluronidase Useful antibody Calretinin Thrombomodulin HBME1 Mesothelin CK 5/6 AE1/AE3(pan (pan-cytokeratin) WT-1 D2-40 ~ ± ~ ± ~ ± CK7.CK20 CEA Ber-EP4 MOC31 31 CAM5.2 34βE12 & 35βE11E11 Electron microscope Numerous, long microvilli Tonofilament Glycogen A few, scattered short icrovilli Tonofilament Glycogen A few, short microvilli Tonofilament Glycogen
59 Mesothelioma 電 顕 写 真 Mesothelial cell Adenocarcinoma
60 Why immunochemical staining is necessary to make a definitive diagnosis of mesothelioma?
61 Case 54-year year-old female Ascites
62
63 CEA CK 7 CEA CK 20 CEA EMA EMA Calretinin 組 織 像
64 Case 54-year year-old female Ascites SSPC(Serous surface papillary carcinoma) NSOCS(normal-sized ovary carcinoma syndrome)
65 Relationship between cytology and histology in the diagnosis of mesothelioma Histology by cell block method using body fluid Body fluid cytology (cell transfer method) Biopsy
66
67 Mesothelioma 1 General remarks 2 Pathology 3 Cytology 4 6 cases of the mesothelioma diagnosed by cytological materials The utility of cell transfer method and cell block method for immunochemical staining
68 Six cases of mesothelioma within 2 years diagnosed in our department were diffecult to detect only by cytological findings. However, the definite diagnosis of mesothelioma was possible by immunochemical staining for several antibodies using cell transfer method and/or cell block method as well as by electron- microscopical examination. So, I would like to emphasize that the definitive diagnosis of mesothelioma is possible from only aspirated body fluid.
69 Case Age sex 60 male 72 male 85 female 84 female 79 male 51 male Asbestos exposure unknown + unknown unknown unknown unkown Clinical diagnosis ascites pleural fluid pleural fluid pleural fluid pleural fluid pleural fluid Hyaluronic acid (ng/ml) 1,110,000 39, ,000 20,700 ND 920,000 Judgement (Class) Ⅱ Ⅴ Ⅲ Ⅳ Ⅲb Ⅳ Ⅲb Ⅳ Ⅳ Immunochemical Staining cell ransfer method cell transfer method cell transfer method cell block method cell transfer Method & cell block mrethod cell ransfer method Electroscopic materials ascites pleural fluid Biopsy material ND Ppleural fluid Pleural fluid Cytological diagnosis mesothelioma mesothelioma mesothelioma mesothelioma mesothelioma mesothelioma Histological findings ND Desmoplastic Mesothelioma Biphasic mesothelioma Epithelioid mesothlioma ND? Follow up (January.2007) Survival (18 momths) Survival (12months) Died (10months) Survival (12months) Dead (6months) Survival (2months)
70 Asbestos Case 1 Age sex exposure Clinical diagnosis Hyaluronic acid (ng/ml) Judgement Immunochemical staining Electroscopic materials Cytological diagnosis Histological findings Follow up (January.2007) 60 male - ascites 1,110,000 ClassⅤ cell transfer method ascites mesothelioma ND Survival (18 momths)
71 Binucleated cells PAS Multinucleated cells Multinucleated cells cell mutual inclusions hump-like protruded cytoplasm
72 Frequency of binucleated and multinucleated cells Mononucleated cell 77% 4% Multinucleated cells 19% Binucleated cells Reactive mesothelial cells binucleated cells<10% multimucleated cells<2%
73 calretinin EMA E-cadherin p53
74 Electron-microscopic findings cell mutual inclusions
75 Case 2 Age sex Asbestos exposure Clinical diagnosis Hyaluronic acid (ng/ml) Judgement Immunochemical staining Electroscopic materials Cytological diagnosis Histological findings Follow up (January.2007) 72 male + pleural fluid 39,900 ClassⅢ cell transfer method Pleural fluid mesothelioma Desmoplastic Mesothelioma Survival (12months)
76 l Binucleated cells Multinucleated cells cell mutual inclusions with hump-like protruded cytoplasm Cell mutual inclusions
77 Frequency of binucleated and multinucleated cells イケナガ Mononucleated cell 70% 24% Binucleated cells 6% Multinucleated cells Reactive mesothelial cells binucleated cells<10% multimucleated cells<2%
78 E-cadherin CK20 Calretinin mesothelin l CK7 CEA CK7
79 Case 3 Age sex Asbestos exposure Clinical diagnosis Hyaluronic acid (ng/ml) Judgement Immunochemical staining Electroscopic materials Cytological diagnosis Histological findings Follow up (January.2007) 85 female - pleural fluid 426,000 Class Ⅳ cell transfer method Tumor tissue mesothelioma Biphasic mesothelioma Died (10months)
80 Binucleated cells Multinucleated cells Pair cells Binucleated cells Cell mutual inclusions
81 Frequency of binucleated and multinucleated cells フジイ Mononucleated cell 66.0% 10% Multinucleated cells 24.0% Binucleated cells Reactive mesothelial cells binucleated cells<10% multimucleated cells<2%
82 EMA Calretinin EMA EMA CK 7 CK20
83 Calretinin CK7 CK20 HE Calretinin
84
85 Case 4 Age sex Asbestos exposure Clinical diagnosis Hyaluronic acid (ng/ml) Judgement Immunochemical staining Electroscopic materials Cytological diagnosis 84 female unknown pleural fluid 20,700 ClassⅣ cell block method ND mesothelioma Histological findings Follow up (January.2007). Epithelioid mesothelioma Alive (12months)
86 binucleated cells CK7 Binucleated cells & Binucleated cells Multinucleated cells
87 Frequency of binucleated and multinucleated cells Mononucleated cell 77% 9% Multinucleated cells 14% Binucleated cells Reactive mesothelial cells binucleated cells<10% multimucleated cells<2%
88 Cell block method HE Calretinin EMA Biopsy CK7 CK20 HE
89 Case 5 Age sex Asbestos exposure 79 male unknown Clinical diagnosis Hyaluronic acid (ng/ml) Judgement Immunochemical Staining Electroscopic materials Cytological diagnosis Histological findingsf Follow up (January.2007). pleural luid ND ClassⅣ Cell transfer Method & cell block method Pleural fluid mesothelioma ND Dead (6months)
90 Multinucleated cells Binucleated cells ell cell mutual inclusion Cell mutual inclusion
91 Frequency of binucleated and multinucleated cells Mononucleated cell 74% 2% Multinucleated cells 24% Binucleated cells Reactive mesothelial cells binucleated cells<10% <10% multimucleated mucleated cells<2% <2%
92 P-53 Calretinin E-cadherin E-カドヘリン
93 Case 6 Age sex Asbestos exposure Clinical diagnosis 51 male unkown pleural fluid Hyaluronic acid (ng/ml) Judgement (Class) Immunochemical Staining Electroscopic materials Cytological diagnosis 920,000 Ⅳ cell ransfer method Pleural fluid mesothelioma Histological findings Follow up (January.2007) Epithelial mesotheliom Survival (2months)
94 Cell mutual inclusion Cell mutual inclusion Binucleated cell
95 Reactive mesothelial cells binucleated cells<10% multimucleated cells<2% Frequency of binucleated and multinucleated cells 単 核 57% 2 核 30% 多 核 (3 核 以 上 ) 13%
96 Immunocytochemical staining by cell tansfer method Calretinin CK5/6 EMA
97 Immunohistochemical staining by cell block method HE Calretinin mesothelin CK5/6 thrombomodulin EMA E-cadherin CEA
98 Immunohistochemical staining by cell block method HE Calretinin mesothelin CK5/6 thrombomodulin EMA E-cadherin CEA
99
100 Thoracoscopic findings Numerous small nodules in the peritoneum Hyaluronic acid 920,000ng/ml
101 Thoracoscopic pleural biopsy HE Calretinin mesothelin CK5/6 C K 5 / 6 D2- HBME-1 EMA CEA
102 Stage 1
103 Stage 1 :Surgical margin(-)
104 Making a definitive diagnosis of mesothelioma by effusion cytology Use of cell transfer method or cell block method for immunochemical staining Maeda Shotaro1, Hosone Masaru1, Katayama Hironori1, Iwase Hiromi1, Kawano Kiyoko1, Yanagida Yumi1, Isobe Hiroaki1, Atarashi Hirotsugu2, Tanimura Shigeo3, and Naito Zenya4 1Department of Pathology, Tama-Nagayama Hospital, Nippon Medical School 2Department of Internal Medicine, Tama-Nagayama Hospital, Nippon Medical School 3Department of Respiratory Surgery, Tama-Nagayama Hospital, Nippon Medical School 4Department of Pathology, Nippon Medical School J.Jpn.Soc.Clin.Cytol.. 47: in press 2008(2)
105 Conclusion 1 1 In diagnosis of the mesothelioma, the information of asbestos exposure, clinical diagnosis( imaging etc.) and the value of hyaluronic acid in the body fluid are important. 2 The early detection of mesothelioma by body fluid cytology y is very important for the improvement of survival rate by pleuropulmonary resection The following cytological finding are important for the diagnosis of mesothelioma. 1The variety of the cytological findings, such as papillary and spherical, large and small clusters, and individual cells. 2The frequency of binucleated and multinucleated cells with large nucleoli. 3pair cells (cell mutual inclusions) with hump-like protruded cytoplasm
106 Conclusion 2 3 Immunostainig for the several antibodies is important for the 4 definite diagnosis of mesothelioma Calretinin CK5/6 CK5/6 D2-40 Thrombomodulin Mesothelin CEA MOC31 MOC31 P53 EMA EMA E-cadherin) Cell transfer method and/or cell block method is useful for the immunocytochemical staining. 5 In cytology of body fluid, the possibility of the mesothelioma should be always kept k in mild. The diagnosis of mesothelioma should be generally performed from the clinical, cytological, immunochemical and electron-microscopical findings.
107 The 1 announcement of the JSCC congress
108
109
110 Case 1 Calretinin p53 Multinucleated cells cell mutual inclusions
111 Case2 l Calretinin E-cadherin Multinucleated cells cell mutual inclusions with hump-like protruded cytoplasm Cell mutual inclusions Binucleated cells
112 Case 3 Calretinin EMA Cell mutual inclusions Cell mutual inclusions
113 Case 4 calretinin EMA
114 Case 5 Cell mutual inclusions Calretinin E-cadherin
115 Case6 Calretinin Acrobat ถ CK5/6 Cell mutual inclusions Cell mutual inclusions
116 Fig 3: Appearance frequencies of mononucleated, binucleated and multinucleated cells as determined by body fluid cavity cytology 100% 80% 4.1% 18.6% 2.3% 24.0% 5.6% 23.6% 10.0% 24.0% 8.7% 14.5% 12.5% 29.7% 60% 40% 77.3% 73.6% 70.8% 66.0% 76.8% 57.8% 20% 0% C ase1 C ase2 C ase3 C ase4 C ase5 C ase6 Multinucleated ce ls 4.1% 2.3% 5.6% 10.0% 8.7% 12.5% Binucleated ce ls 18.6% 24.0% 23.6% 24.0% 14.5% 29.7% M ononucleated cells 77.3% 73.6% 70.8% 66.0% 76.8% 57.8%
117 Multinucleated cells 4 Dense cytoplasm Prominent nucleoli
118 binucleated cells
119 Introduction(general remarks) of mesothelioma Asbestos body Binucleated mesothelioma cell
120 Mesothelioma Lung cancer The number of asbestos related mesothelioma and lung cancer authorized by government 独 立 法 人 環 境 再 生 保 全 機 構
121 Cytology of mesothelioma Binucleated mesothelioma cell
122 Cell transfer method It takes 1 and half hours----- Taking off the cover glass Pasting the mount Softening the mount Transfer 3X6=18 Taking off the mount Trimming
123 患 者 の 救 済 申 請 独 立 行 政 法 人 環 境 再 生 保 全 機 構 (2007 年 ) 3 救 済 給 付 の 種 類 ( 2 頁 ) 現 在 療 養 中 の 方 への 給 付 医 療 費 ( 本 人 が 請 求 ) 自 己 負 担 分 療 養 手 当 ( 本 人 が 請 求 ) ,870 円 / 月 認 定 後 療 養 中 の 方 がお 亡 くなりになった 場 合 の 給 付 葬 祭 料 ,999 円 救 済 給 付 調 整 金 個 別 に 算 定 7 労 災 補 償 制 度 又 は 特 別 遺 族 給 付 金 について( 頁 ) 医 学 的 判 定 に 係 わる 資 料 に 関 する 留 意 事 項 (3) 病 理 組 織 学 的 検 査 記 録 がない 場 合 について (ア) 細 胞 診 については パパニコロウ 染 色 による 形 態 的 特 徴 及 び 免 疫 染 色 の 結 果 については 詳 細 に 記 載 すること (イ) 陽 性 となる 抗 体 としてcalretinin calretinin 陰 性 となる 抗 体 としてCEA CEAを を 用 いた 免 疫 染 色 の 結 果 を 添 付 すること が 強 く 推 奨 されること 上 記 以 外 の 陽 性 となる 抗 体 としてcytokeratin cytokeratin5/6 thrombomodulin D2-40 などが 陰 性 となる 抗 体 として Ber Ber-EP4 MOC-31などがあり こららの 抗 体 を 用 いた 免 疫 染 色 の 結 果 も 参 考 になる 場 合 があること
124 Body fluid for cell block method
125 Fig.. 2 Cell block method 1. Body fluid 2. Centrifuge at 1500rpm for 5minutes 3.Fixtation 4. Cell block 5.Immunochemical staining 1.Ask clinical department to submit as much body cavity fluid as possible. 2.Centrifuge the body cavity fluid (1500 rpm for 5 minutes). 3.Decant the supernatant into another container, add 1-2 ml of 20% formalin to the supernatant, and fix overnight. 4.Embed the pellets in paraffin to prepare cell blocks. 5.Carry out immunochemical staining.
126 Useful antibodies for diagnosis of mesothelioma (The journal of JSCC:1970~2006) 1985 keratin 1988 EMA vimentin 1996 thrombomodulin 1997 mesothelin 2000 calretinin 2001 CK5/ WT D2-40
127 E-cadherin CEA CK20 Immunohistochemical staining using cell tranfer method in a case of mesothelioma Calretinin mesothelin l CK7
128 中 皮 腫 の 確 定 診 断 のために 何 故 免 疫 染 色 が 必 要 か!! 診 断 の 確 認!!
129 Body fluid for cell block method
130
131 Mesothelioma cells VS Reactive mesothelial cells 写 真 追 加 Variety Multinucleated cells Binucleated cells Reactive mesothelial cells Uniformity
132 Multinucleated cells 4 Dense cytoplasm Prominent nucleoli
133
134
135 Making a definitive diagnosis of mesothelioma by effusion cytology The utility of cell transfer method and cell block method for immunocytochemical staining Maeda Shotaro1, Katayama Hironori1,Naito Zenya2 1Department of Pathology, Tama-Nagayama Hospita,, Nippon Medical School 2Department of Pathology, Nippon Medical School
136 70 year old male
137
The develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
Diagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
Effusions: Mesothelioma and Metastatic Cancers
Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,
Practical Effusion Cytology
Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%
Notice of Faculty Disclosure
The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada [email protected] Notice of Faculty Disclosure In accordance with
Survey of Mesothelioma Associated with Asbestos Exposure in Japan
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
How To Diagnose And Treat A Tumour In An Effusion
Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura
Outline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
How To Test For Cancer
Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic
Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!
Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of
Cytopathology Case Presentation #8
Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents
20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.
Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and Malignant Mesothelioma in Effusions Robert T. Pu,
3-F. Pathology of Mesothelioma
3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download
AP2003R1 http://hkcpath.org. Correspondence: [email protected] 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from
J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
Document and entity information
Company information Company information FASF member mark Document name Document and entity information Aug 2015 第 3 四 半 期 決 算 短 信 日 本 基 準 ( 連 結 ) Filing date 20150710 Company name TRANSACTION CO., Ltd.
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have
ALTHOUGH excellent accounts have been published in recent years of
THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA BERNARD NAYLOR Department of Pathology, University of Michigan, Ann Arbor, Michigan, U.S.A. PLATE~ LXXXVI-XCI ALTHOUGH excellent accounts have
Case presentation. Awatif Al-Nafussi
Case presentation Awatif Al-Nafussi Case History 49 year old DVT & small PE June 08, Pelvic mass Ca125 33 Laparotomy-TAHBSO, drainage of ascites Ovarian carcinoma Clinical diagnosis Multiple specimens
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.
5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen
Diagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 [email protected]
Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.
Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum. Protocol revision date: January 2004 No AJCC/UICC staging system
Malignant Mesothelioma
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Malignant Mesothelioma
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Case of the. Month October, 2012
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
Video Microscopy Tutorial 5
Video Microscopy Tutorial 5 Lool Alikes in Effusion Cytology:Review of Diagnostic Challenges Claire Michael, MD There are no disclosures necessary. Look-Alikes in Effusion Cytology: Review of Diagnostic
Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy
CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,
Today s Topics. Tumors of the Peritoneum in Women
Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA [email protected]
Carcinosarcoma of the Ovary
Carcinosarcoma of the Ovary A Rare Finding Presented By: Kathryn Kiely Anisa I. Kanbour School of Cytotechnology of the University of Pittsburgh Medical Center Pittsburgh, PA Patient History 55 year old
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND
Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma -
The Korean Journal of Pathology 2009; 43: 458-66 DOI: 10.4132/KoreanJPathol.2009.43.5.458 Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma
Cost Accounting 1. B r e a k e v e n A n a l y s i s. S t r a t e g y I m p l e m e n t a t i o n B a l a n c e d S c o r e c a r d s
Cost Accounting 1 B r e a k e v e n A n a l y s i s S t r a t e g y I m p l e m e n t a t i o n B a l a n c e d S c o r e c a r d s S t r a t e g y M o n i t o r i n g R e s p o n s i b i l i t y S e g
Pathology of the Female Peritoneum, Common and Uncommon Problems
Pathology of the Female Peritoneum, Common and Uncommon Problems An Update on Gynecologic Pathology Florence, Italy Anaís Malpica, M.D. Professor of Pathology Pathology of the Female Peritoneum Keratin
بسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Rare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum
Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors and malignant mesothelial neoplasms of the
レッドハット 製 品 プライスリスト Red Hat Enterprise Linux2013 新 製 品 (ベースサブスクリプション) 更 新 :2015 年 4 22
Red Hat Enterprise Linux2013 新 製 品 (ベースサブスクリプション) 更 新 :2015 年 4 22 薄 紫 :3 年 型 番 :5 年 型 番 字 : 新 規 追 加 変 更 新 規 新 規 SKU 製 品 名 ソケット ゲストOS サポート 期 間 標 準 価 格 備 考 Server RH00001 Red Hat Enterprise Linux for Virtual
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT Written by: Karyn Varley MS, SCT(ASCP) The donating laboratory would like to remain anonymous. PATIENT HISTORY 28 year old female Lived
育 デジ (Iku-Digi) Promoting further evolution of digital promotion
育 デジ (Iku-Digi) Promoting further evolution of digital promotion Abstract Digital promotion has established its presence and become a commodity in the pharmaceutical industry. In the last few years, use
Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours
Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains
INFLAMMATORY PLEURAL EFFUSION
PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary
H istochem istry in the Diagnosis o f M alignant M esotheliom a *
A n n a l s o f C l i n i c a l L a b o r a t o r y S c i e n c e, Vol. 3, No. 3 Copyright 1973, Institute for Clinical Science H istochem istry in the Diagnosis o f M alignant M esotheliom a * MILTON
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
Data Mining for Risk Management in Hospital Information Systems
Data Mining for Risk Management in Hospital Information Systems Shusaku Tsumoto and Shoji Hirano Department of Medical Informatics, Shimane University, School of Medicine, 89-1 Enya-cho, Izumo 693-8501
What is Mesothelioma?
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
Mesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
この 外 国 弁 護 士 による 法 律 事 務 の 取 扱 いに 関 する 特 別 措 置 法 施 行 規 則 の 翻 訳 は 平
この 外 国 弁 護 士 による 法 律 事 務 の 取 扱 いに 関 する 特 別 措 置 法 施 行 規 則 の 翻 訳 は 平 成 十 六 年 法 務 省 令 第 6 号 までの 改 正 ( 平 成 16 年 4 月 1 日 施 行 )について 法 令 用 語 日 英 標 準 対 訳 辞 書 ( 平 成 18 年 3 月 版 )に 準 拠 して 作 成 したものです なお この 法 令 の 翻
How To Defend The Mesothelioma Case
Defending the Mesothelioma Case: Types, Alternative Causes, and Working Up the Case Mary Price Birk Baker & Hostetler, LLP 303 East 17 th Avenue, Suite 1100 Denver, CO 80202 (303) 764-4041 (303) 861-7805
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center [email protected] 66 th Annual Pathology Seminar California Society of Pathologists Short
A 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,
Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.
Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case
Case based applications part III
Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.
Recommendations for the Reporting of Pleural Mesothelioma
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma
A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma MICHAEL G. HURTUK and MICHELE CARBONE Cardinal Bernadin Cancer Center, Cancer Immunology Program, Department of Pathology,
Role of immunohistochemistry
Tumors of serous membranes of difficult diagnosis: Dr. Hector Battifora Role of immunohistochemistry Abstract: The most common differential diagnosis of tumors involving serosal surfaces is adenocarcinoma
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Direct Marketing Production Printing & Value-Added Services: A strategy for growth
2015 年 12 月 Direct Marketing Production Printing & Value-Added Services: A strategy for growth 完 成 のご 案 内 ダイレクトマーケティングにおける 印 刷 物 & 付 加 価 値 サービス : 成 長 への 戦 略 とは? 印 刷 物 を 活 用 したダイレクトマーケティングが 成 長 しており デジタル
Panasonic AC-DC Power Supply Design Support Service
Panasonic AC-DC Power Supply Design Support Service The best solution to design your AC-DC power supply (how to design a switching power supply, order a transformer, prevent EMI, etc.) Panasonic s IPD
Electricity Business Act ( Act No. 170 of July 11, 1964)
この 電 気 事 業 法 の 翻 訳 は 平 成 十 七 年 法 律 第 八 十 七 号 までの 改 正 ( 平 成 18 年 5 月 1 日 施 行 )について 法 令 用 語 日 英 標 準 対 訳 辞 書 ( 平 成 18 年 3 月 版 )に 準 拠 して 作 成 したものです なお この 法 令 の 翻 訳 は 公 定 訳 ではありません 法 的 効 力 を 有 するのは 日 本 語 の
Teacher Training and Certificate System
Teacher Training and Certificate System 1. Teacher Training Teacher training in Japan started with the establishment of normal schools (schools for teacher training) in 1872. In 1886, a higher normal school
ORIGINAL ARTICLES. Materials and Methods
ORIGINAL ARTICLES Cytomorphologic Features of Metastatic Urothelial Carcinoma in Serous Effusions Cheng Cheng Huang, M.D., PH.D., 1 Anoja Attele, M.D., 1 and Claire W. Michael, M.D. 2 * Metastatic urothelial
Cytopathology of Pleural Mesotheliomas
Cytopathology of Pleural Mesotheliomas Gia-Khanh Nguyen, MD Key Words: Pleural mesothelioma; Epithelial mesothelioma; Sarcomatous mesothelioma; Mixed mesothelioma; Exfoliative cytology; Fineneedle aspiration
Standards and datasets for reporting cancers. Dataset for the histological reporting of mesothelioma. April 2013
Standards and datasets for reporting cancers Dataset for the histological reporting of mesothelioma April 2013 Authors Professor Andrew G Nicholson, Royal Brompton Hospital and Harefield NHS Trust Professor
Summary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
医 学 生 物 学 一 般 問 題 ( 問 題 用 紙 1 枚 解 答 用 紙 2 枚 )
平 成 26 年 度 大 学 院 医 学 研 究 科 博 士 課 程 入 学 試 験 (1 回 目 ) 医 学 生 物 学 一 般 問 題 ( 問 題 用 紙 1 枚 解 答 用 紙 2 枚 ) 以 下 の 問 題 1 問 題 4のうち 二 つの 問 題 を 選 択 して 解 答 しなさい 一 つの 問 題 につき1 枚 の 解 答 用 紙 を 使 用 しなさい 紙 面 不 足 の 場 合 は 裏
レッドハット 製 品 プライスリスト Red Hat Enterprise Linux 製 品 (RHEL for HPC) 更 新 :2015 年 4 22
レッドハット 製 品 プライスリスト Red Hat Enterprise Linux 製 品 (RHEL for HPC) 更 新 :2015 年 4 22 薄 紫 :3 年 型 番 :5 年 型 番 字 : 新 規 追 加 変 更 当 価 格 表 は 予 告 なしに 変 更 する 場 合 がございますので ご 了 承 ください 価 格 は 全 て 税 抜 きでの 掲 載 となっております 新 規
Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis
Case Reports in Pulmonology Volume 2015, Article ID 962504, 4 pages http://dx.doi.org/10.1155/2015/962504 Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement
Asbestos and the diseases it causes
Asbestos and the diseases it causes October 2013 Liz Darlison Mesothelioma UK University Hospitals of Leicester Contents What is asbestos Why is it such an issue in the UK Disease Statistics Asbestos Related
Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child
Int J Clin Exp Pathol 2014;7(5):2636-2640 www.ijcep.com /ISSN:1936-2625/IJCEP0000187 Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child Qihan You 1, Jing
Post-Mortem Diagnosis of a Rare Biphasic Benign Multicystic Peritoneal Mesothelioma in an Indian Domestic Fowl (Gallus Domesticus)
ISSN 2320-5407 International Journal of Advanced Research (2014), Volume 2, Issue 7, 380-384 Journal homepage: http://www.journalijar.com INTERNATIONAL JOURNAL OF ADVANCED RESEARCH RESEARCH ARTICLE Post-Mortem
Neoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Case presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane
Case presentation: Mesothelioma of the tunica vaginalis Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane A 76 year old man presented June 2011 with a 6 month history of painless
Ovarian tumors Ancillary methods
Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of
Pleural Mesothelioma: An Institutional Experience of 66 Cases
The Korean Journal of Pathology 2014; 48: 91-99 ORIGINAL ARTICLE Pleural Mesothelioma: An Institutional Experience of 66 Cases Soomin Ahn In Ho Choi Joungho Han Jhingook Kim 1 Myung-Ju Ahn 2 Departments
3- B ~ E. Asbestos-Related Respiratory Diseases
3- B ~ E. Asbestos-Related Respiratory Diseases Takumi Kishimoto Deputy-director, Okayama Rosai Hospital, Japan Summary For the pulmonary diseases arising from asbestos there are benign lesions from asbestosis
PROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
Understanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
Public Financial Assistance for Formal Education in Japan
Public Financial Assistance for Formal Education in Japan In Japan, households bear a particularly high proportion of the costs of pre-primary and tertiary education compared with other OECD countries
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
Pathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
Asbestos Related Diseases
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through
